Testing effectiveness (Phase 2)Study completedNCT01928420
What this trial is testing
A Single Site, Randomized, Double-blind, Placebo Controlled Trial of NIC5-15 in Subjects With Alzheimer's Disease
Who this might be right for
Alzheimer's DiseaseDementia
Humanetics Corporation 30